217 related articles for article (PubMed ID: 28467807)
21. Pyroglutamylated amyloid-β peptide reverses cross β-sheets by a prion-like mechanism.
Matos JO; Goldblatt G; Jeon J; Chen B; Tatulian SA
J Phys Chem B; 2014 May; 118(21):5637-43. PubMed ID: 24802697
[TBL] [Abstract][Full Text] [Related]
22. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
23. Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer's disease.
Lee MC; Yu WC; Shih YH; Chen CY; Guo ZH; Huang SJ; Chan JCC; Chen YR
Sci Rep; 2018 Mar; 8(1):4772. PubMed ID: 29555950
[TBL] [Abstract][Full Text] [Related]
24. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
Sun Y; Qian Z; Wei G
Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Sharma S; Nehru B; Saini A
Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
[TBL] [Abstract][Full Text] [Related]
26. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of amyloid-β aggregation in Alzheimer's disease.
Wang Q; Yu X; Li L; Zheng J
Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo.
Hong HS; Rana S; Barrigan L; Shi A; Zhang Y; Zhou F; Jin LW; Hua DH
J Neurochem; 2009 Feb; 108(4):1097-1108. PubMed ID: 19141069
[TBL] [Abstract][Full Text] [Related]
29. Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies.
Robinson M; Lou J; Mehrazma B; Rauk A; Beazely M; Leonenko Z
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494369
[TBL] [Abstract][Full Text] [Related]
30. An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.
Adolfsson O; Pihlgren M; Toni N; Varisco Y; Buccarello AL; Antoniello K; Lohmann S; Piorkowska K; Gafner V; Atwal JK; Maloney J; Chen M; Gogineni A; Weimer RM; Mortensen DL; Friesenhahn M; Ho C; Paul R; Pfeifer A; Muhs A; Watts RJ
J Neurosci; 2012 Jul; 32(28):9677-89. PubMed ID: 22787053
[TBL] [Abstract][Full Text] [Related]
31. [Cell-surface Initial Aggregation Process of Amyloid-β Peptides Studied by Fluorescence Correlation Spectroscopy].
Yano Y
Yakugaku Zasshi; 2021; 141(6):825-829. PubMed ID: 34078789
[TBL] [Abstract][Full Text] [Related]
32. Inherent anti-amyloidogenic activity of human immunoglobulin gamma heavy chains.
Adekar SP; Klyubin I; Macy S; Rowan MJ; Solomon A; Dessain SK; O'Nuallain B
J Biol Chem; 2010 Jan; 285(2):1066-74. PubMed ID: 19889627
[TBL] [Abstract][Full Text] [Related]
33. Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP).
Williams TL; Serpell LC; Urbanc B
Biochim Biophys Acta; 2016 Mar; 1864(3):249-259. PubMed ID: 26699836
[TBL] [Abstract][Full Text] [Related]
34. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies.
Zheng Q; Kebede MT; Kemeh MM; Islam S; Lee B; Bleck SD; Wurfl LA; Lazo ND
Molecules; 2019 Jun; 24(12):. PubMed ID: 31234523
[TBL] [Abstract][Full Text] [Related]
36. Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease.
Xiao Y; Ma B; McElheny D; Parthasarathy S; Long F; Hoshi M; Nussinov R; Ishii Y
Nat Struct Mol Biol; 2015 Jun; 22(6):499-505. PubMed ID: 25938662
[TBL] [Abstract][Full Text] [Related]
37. The Alzheimer's amyloid-β(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization.
Tay WM; Huang D; Rosenberry TL; Paravastu AK
J Mol Biol; 2013 Jul; 425(14):2494-508. PubMed ID: 23583777
[TBL] [Abstract][Full Text] [Related]
38. Aggregation pathways of the amyloid β(1-42) peptide depend on its colloidal stability and ordered β-sheet stacking.
Jiang D; Rauda I; Han S; Chen S; Zhou F
Langmuir; 2012 Sep; 28(35):12711-21. PubMed ID: 22870885
[TBL] [Abstract][Full Text] [Related]
39. A discrete mathematical model for the aggregation of β-Amyloid.
Dayeh MA; Livadiotis G; Elaydi S
PLoS One; 2018; 13(5):e0196402. PubMed ID: 29791461
[TBL] [Abstract][Full Text] [Related]
40. Probing oligomerization of amyloid beta peptide in silico.
Dorosh L; Stepanova M
Mol Biosyst; 2016 Dec; 13(1):165-182. PubMed ID: 27844078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
